Cymat Technologies Ltd.
CYMHF
$0.07
$0.00-5.00%
OTC PK
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -25.46% | -90.37% | -5.51% | 361.71% | 193.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.46% | -90.37% | -5.51% | 361.71% | 193.86% |
| Cost of Revenue | -72.44% | -70.71% | 328.87% | 120.87% | -5.18% |
| Gross Profit | 177.38% | -141.59% | -280.13% | 368.32% | 62.27% |
| SG&A Expenses | 35.15% | -15.48% | 3.10% | -27.90% | -21.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.25% | -54.22% | 41.56% | 17.36% | -13.83% |
| Operating Income | 2.48% | -224.02% | -58.42% | 68.24% | 33.45% |
| Income Before Tax | -3.16% | -118.88% | -49.46% | 44.17% | 24.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.16% | -118.88% | -49.46% | 44.17% | 24.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.16% | -118.88% | -49.46% | 44.17% | 24.30% |
| EBIT | 2.48% | -224.02% | -58.42% | 68.24% | 33.45% |
| EBITDA | 3.63% | -454.42% | -66.07% | 75.70% | 34.54% |
| EPS Basic | 20.75% | -86.67% | -56.67% | 44.17% | 29.33% |
| Normalized Basic EPS | 21.21% | -81.58% | -64.29% | 44.00% | 29.79% |
| EPS Diluted | 20.75% | -86.67% | -56.67% | 44.17% | 29.33% |
| Normalized Diluted EPS | 21.21% | -81.58% | -64.29% | 44.00% | 29.79% |
| Average Basic Shares Outstanding | 30.89% | 18.03% | -4.48% | 0.08% | 6.78% |
| Average Diluted Shares Outstanding | 30.89% | 18.03% | -4.48% | 0.08% | 6.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |